daunoform

a daunorubicin-formaldehyde conjugate; structure in first source

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 08/01/1997 - "Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells." 07/01/1999 - "Synthetic formaldehyde conjugates of DOX, DAU, and EPI, denoted Doxoform (DOXF), Daunoform (DAUF), and Epidoxoform (EPIF), exhibit enhanced toxicity to anthracycline-sensitive and -resistant tumor cells. "
2.	Breast Neoplasms (Breast Cancer) 06/01/2000 - "Selected ion flow tube-chemical ionization mass spectrometry was used to measure formaldehyde levels in human breast cancer cells in comparison with levels in cells treated with the antitumor drugs doxorubicin (DOX) and daunorubicin (DAU) and the daunorubicin-formaldehyde conjugate Daunoform (DAUF). " 04/09/1998 - "The recent discovery that the formaldehyde conjugates of doxorubicin and daunorubicin, Doxoform and Daunoform, are cytotoxic to resistant human breast cancer cells prompted the search for hydrolytically more stable anthracycline-formaldehyde conjugates. "

1.	Formaldehyde (Formol)
2.	Anthracyclines
3.	doxoform
4.	Doxorubicin (Adriamycin)
5.	Daunorubicin (Cerubidine)
6.	Antineoplastic Agents (Antineoplastics)
7.	epidoxoform